Ihre Browserversion ist veraltet. Wir empfehlen, Ihren Browser auf die neueste Version zu aktualisieren.

108. Pantelić, N., Stanojković, T. P., Zmejkovski, B. B., Sabo, T. J. and Kaluđerović, G. N. (2015):
        In vitro anticancer activity of gold(III) complexes with some esters of (S,S)-ethylenediamine-N,
        N′-di-2-propanoic acid,
        Europ. J. Med. Chem. 90, 766–774.

109. Momcilovic, M.,  Eichhorn, T., Blazevski, J., Schmidt, H., Kaluđerović, G. N. and Stosic-Grujicic, S.
       (2015):
       In vitro effects of binuclear (η6-p-cymene)ruthenium(II) complex containing bridging bis(nicotinate)-
        polyethylene glycol ester ligand on differentiation pathways of murine Th lymphocytes activated by
        T cell mitogen
        J. Biol. Inorg. Chem. 30, 578–853.

110. Bulatović, M., Kaluđerović, M. R., Mojić, M., Zmejkovski, B. B., Hey-Hawkins, E., Vidaković, M.,
        Grdović, N., Kaluđerović, G. N., Mijatović, S., Maksimović-Ivanić, D. (2015):
        Improved in vitro antitumor potential of
        (O,O'-diisobutyl-ethylenediamine-N,N'-di-3-propionate)tetrachloridoplatinum(IV) complex
        under normoxic and hypoxic conditions.
        Eur. J. Pharmacol. 760, 136–144.

111.  Kaluđerović, G. N., Krajnović, T., Momcilovic, M., Stosic-Grujicic, S., Mijatović, S., Maksimović-Ivanić,
        D., Hey-Hawkins, E. (2015):
        Ruthenium(II) p-cymene complex bearing 2,2’-dipyridylamine targets caspase 3 deficient MCF-7
        breast cancer cells without disruption of antitumor immune response,
        J. Inorg. Biochem. 153, 315–321.